Evidence map›Paper›PMID 33667553›Full record

ReviewInternational journal of biological macromolecules2021

The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play.

Pedro F N Souza, Felipe P Mesquita, Jackson L Amaral, Patrícia G C Landim, Karollyny R P Lima, Marília B Costa, Izabelle R Farias, Luina B Lima, Raquel C Montenegro

Open access · greenAbstract readReview
In one paragraph

Review in International journal of biological macromolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Future virology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Pedro F N SouzaDepartment of Biochemistry and Molecular Biology, Federal University of Ceara, Brazil. Electronic address: pedrofilhobio@gmail.com.
Felipe P MesquitaDrug research and Development Center, Department of Medicine, Federal University of Ceara, Brazil.
Jackson L AmaralDepartment of Biochemistry and Molecular Biology, Federal University of Ceara, Brazil.
Patrícia G C LandimDepartment of Biochemistry and Molecular Biology, Federal University of Ceara, Brazil.
Karollyny R P LimaDepartment of Biochemistry and Molecular Biology, Federal University of Ceara, Brazil.
Marília B CostaDrug research and Development Center, Department of Medicine, Federal University of Ceara, Brazil.
Izabelle R FariasDrug research and Development Center, Department of Medicine, Federal University of Ceara, Brazil.
Luina B LimaDrug research and Development Center, Department of Medicine, Federal University of Ceara, Brazil.
Raquel C MontenegroDrug research and Development Center, Department of Medicine, Federal University of Ceara, Brazil.
Universidade Federal do Ceará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three coronaviruses (CoVs) have threatened the world population by causing outbreaks in the last two decades. In late 2019, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged and caused the coronaviruses to disease 2019 (COVID-19), leading to the ongoing global outbreak. The other pandemic coronaviruses, SARS-CoV and Middle East respiratory syndrome CoV (MERS-CoV), share a considerable level of similarities at genomic and protein levels. However, the differences between them lead to distinct behaviors. These differences result from the accumulation of mutations in the sequence and structure of spike (S) glycoprotein, which plays an essential role in coronavirus infection, pathogenicity, transmission, and evolution. In this review, we brought together many studies narrating a sequence of events and highlighting the differences among S proteins from SARS-CoV, MERS-CoV, and SARS-CoV-2. It was performed here, analysis of S protein sequences and structures from the three pandemic coronaviruses pointing out the mutations among them and what they come through. Additionally, we investigated the receptor-binding domain (RBD) from all S proteins explaining the mutation and biological importance of all of them. Finally, we discuss the mutation in the S protein from several new isolates of SARS-CoV-2, reporting their difference and importance. This review brings into detail how the variations in S protein that make SARS-CoV-2 more aggressive than its relatives coronaviruses and other differences between coronaviruses.

Indexed as

AnimalsCoronavirus InfectionsCOVID-19HumansMiddle East Respiratory Syndrome CoronavirusPandemicsProtein BindingSARS-CoV-2Severe acute respiratory syndrome-related coronavirusSpike Glycoprotein, CoronavirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2CoronavirusesMERS-CoVMutationsRBDSARS-CoVSARS-CoV-2Spike proteins

Identifiers

PMID33667553
PMCPMC7921731
OpenAlexW3135665172

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.